Journal of General Virology, Vol 79, 1373-1381, Copyright © 1998 by Society for General Microbiology

ARTICLES

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity

G Duverlie, H Khorsi, S Castelain, O Jaillon, J Izopet, F Lunel, F Eb, F Penin and C Wychowski
Virologie, CHU-Hopital Sud, Amiens, France. duverlie@infobiogen.fr

Japanese studies have defined the discrete 2209-2248 amino acid region of the non-structural 5A protein (NS5A(2209-2248)) of hepatitis C virus genotype 1b (HCV 1b) isolates as the interferon sensitivity determining region (ISDR). European studies did not confirm these results since most of the ISDR sequences harboured an intermediate profile. Recently, a direct interaction between the NS5A protein, involving the ISDR, and the interferon-induced protein kinase (PKR) has been reported and presented as a possible explanation of HCV interferon resistance. In the present study, the entire NS5A amino acid sequence from 11 resistant and eight sensitive strains from European HCV 1b isolates was inferred from direct sequencing. The previously described important amino acid stretches and positions in NS5A were compared between the resistant and sensitive groups. Although some variations were observed, no clear differences could be directly correlated with the interferon sensitivity. However, sensitive strains were different, owing to more amino acid changes when compared to a consensus sequence from all strains. The carboxy-terminal region and especially the previously reported NS5A/V3 region showed most of the variations. Moreover, the conformational analysis of NS5A by secondary structure prediction allowed the differentiation of most sensitive strains from resistant ones. It was concluded that other regions different from ISDR were involved in resistance to interferon maybe via the interaction between NS5A and PKR.

This article has been cited by other articles:

				P. Munoz de Rueda, J. Casado, R. Paton, D. Quintero, A. Palacios, A. Gila, R. Quiles, J. Leon, A. Ruiz-Extremera, and J. Salmeron Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses J. Virol., July 1, 2008; 82(13): 6644 - 6653. [Abstract] [Full Text] [PDF]

				T. Abe, Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, et al. Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines J. Virol., September 1, 2007; 81(17): 8953 - 8966. [Abstract] [Full Text] [PDF]

				M. Torres-Puente, J. M. Cuevas, N. Jimenez-Hernandez, M. A. Bracho, I. Garcia-Robles, F. Carnicer, J. del Olmo, E. Ortega, A. Moya, and F. Gonzalez-Candelas Contribution of insertions and deletions to the variability of hepatitis C virus populations J. Gen. Virol., August 1, 2007; 88(8): 2198 - 2203. [Abstract] [Full Text] [PDF]

				M. J. Donlin, N. A. Cannon, E. Yao, J. Li, A. Wahed, M. W. Taylor, S. H. Belle, A. M. Di Bisceglie, R. Aurora, J. E. Tavis, et al. Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy J. Virol., August 1, 2007; 81(15): 8211 - 8224. [Abstract] [Full Text] [PDF]

				A. Wohnsland, W. P. Hofmann, and C. Sarrazin Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Clin. Microbiol. Rev., January 1, 2007; 20(1): 23 - 38. [Abstract] [Full Text] [PDF]

				F. Puig-Basagoiti, X. Forns, I. Furcic, S. Ampurdanes, M. Gimenez-Barcons, S. Franco, J. M. Sanchez-Tapias, and J.-C. Saiz Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C J. Gen. Virol., April 1, 2005; 86(4): 1067 - 1075. [Abstract] [Full Text] [PDF]

				M Pascu, P Martus, M Hohne, B Wiedenmann, U Hopf, E Schreier, and T Berg Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences Gut, September 1, 2004; 53(9): 1345 - 1351. [Abstract] [Full Text] [PDF]

				T. Taguchi, M. Nagano-Fujii, M. Akutsu, H. Kadoya, S. Ohgimoto, S. Ishido, and H. Hotta Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner J. Gen. Virol., April 1, 2004; 85(4): 959 - 969. [Abstract] [Full Text] [PDF]

				J. VYAS, A. ELIA, and M. J. CLEMENS Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA RNA, July 1, 2003; 9(7): 858 - 870. [Abstract] [Full Text] [PDF]

				C. Sarrazin, E. Herrmann, K. Bruch, and S. Zeuzem Hepatitis C Virus Nonstructural 5A Protein and Interferon Resistance: a New Model for Testing the Reliability of Mutational Analyses J. Virol., October 2, 2002; 76(21): 11079 - 11090. [Abstract] [Full Text] [PDF]

				M. I. Lusida, M. Nagano-Fujii, C. A. Nidom, Soetjipto, R. Handajani, T. Fujita, K. Oka, and H. Hotta Correlation between Mutations in the Interferon Sensitivity-Determining Region of NS5A Protein and Viral Load of Hepatitis C Virus Subtypes 1b, 1c, and 2a J. Clin. Microbiol., November 1, 2001; 39(11): 3858 - 3864. [Abstract] [Full Text] [PDF]

				S. J. Polyak, K. S. A. Khabar, D. M. Paschal, H. J. Ezelle, G. Duverlie, G. N. Barber, D. E. Levy, N. Mukaida, and D. R. Gretch Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin-8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response J. Virol., July 1, 2001; 75(13): 6095 - 6106. [Abstract] [Full Text] [PDF]

				K Nagayama, N Enomoto, N Izumi, M Kurosaki, Y Miyasaka, H Watanabe, J Itakura, C-H Chen, J Tazawa, Y Hoshino, et al. Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients Gut, June 1, 2001; 48(6): 830 - 835. [Abstract] [Full Text] [PDF]

				J.-B. Nousbaum, S. J. Polyak, S. C. Ray, D. G. Sullivan, A. M. Larson, R. L. Carithers Jr., and D. R. Gretch Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy J. Virol., October 1, 2000; 74(19): 9028 - 9038. [Abstract] [Full Text]

				C. François, G. Duverlie, D. Rebouillat, H. Khorsi, S. Castelain, H. E. Blum, A. Gatignol, C. Wychowski, D. Moradpour, and E. F. Meurs Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis J. Virol., June 15, 2000; 74(12): 5587 - 5596. [Abstract] [Full Text]

				N. N. Zein Clinical Significance of Hepatitis C Virus Genotypes Clin. Microbiol. Rev., April 1, 2000; 13(2): 223 - 235. [Abstract] [Full Text] [PDF]